Skip to content

Avanos Medical AVNS Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Cardinal Health logo
Cardinal HealthCAH
Boston Scientific logo
Boston ScientificBSX
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
Medtronic logo
MedtronicMDT
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
IAR
Integra LifeSciencesIART

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B+108%
Enterprise value$1.24B+105%
P/S1.6×+0.8×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's common stock, shares authorized (in shares)?
Avanos Medical (AVNS) reported common stock, shares authorized (in shares) of $300M in Q1 2026.
How has Avanos Medical's common stock, shares authorized (in shares) changed year-over-year?
Avanos Medical's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $300M to $300M.
What is the long-term trend for Avanos Medical's common stock, shares authorized (in shares)?
Over 5 years (2020 to 2025), Avanos Medical's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $300M to $300M.